Congratulations on your new role. What are the main agendas behind the recently announced dual leadership at E...Read more
Japan based Chugai Pharmaceutical Co., Ltd. has announced that it is working to start a Phase III clinical tri...Read more
A world-first trial will see researchers from Australia's Austin Health and the University of Melbourne,&...Read more
Netherlands based Viroclinics Biosciences, a leading virology contract research organization, has announced th...Read more
80 + trails underway to treat COVID-19
In just over 90 days of identification of a pneumonia of unknown cause, the novel coronavirus pandemic, which is raging around the world and posing a challenge for all countries and regions. As on April 2,2020 the number of confirmed COVID-19 cases worldwide has risen above 1 million, according to the new tally fromJohns Hopkins University. Since the emergence of the novel coronavirus (COVID-19 ) biopharmaceutical companies across the world have stepped up their research efforts to develop vaccines and treatments in order to contain the virus. As of March 26, 2020, there are a number of therapeutics currently in clinical trials and more than 52 candidate vaccines are in preclinical evaluation for COVID-19 and 2 candidate vaccines are in clinical evaluation. Over 80 clinical trials are underway to test new and existing medicines across the globe.